‘Doctor Who’ returning with a bang, says showrunner Chris Chibnall
Team Udayavani, Dec 7, 2019, 4:29 PM IST
Los Angeles: Showrunner Chris Chibnall has said the first two episodes of the new season of “Doctor Who” will be an “action-packed, location-packed, rollercoaster” ride.
In an interview with Entertainment Weekly, Chibnall dubbed the two-part series opener, titled “Spyfall”, as a massive event story that will push the boundary for sci-fi storytelling.
“We start with a two-part, two-hour massive event story. It is an absolute action-packed, location-packed, rollercoaster ride of a story. Probably one of our biggest stories ever in the history of the show. So, we’re coming back with a bang, I think, is the shorthand phrase,” the showrunner said.
“Spyfall”, which will premiere on January 1, 2020, will mark the return of Jodie Whitaker as the titular time-travelling character.
The story finds MI6 turning to the Doctor and his friends for help after intelligence agents around the world are under attack from alien forces.
The episode will feature guest appearances by veteran British actors Stephen Fry and Lenny Henry.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Aditi Rao Hydari, Siddharth are married
Amid Bengaluru water crisis, film star Chiranjeevi shares tips on building eco-friendly houses
Vin Diesel shares new pic with Deepika Padukone, says he had promised her to visit India
‘Big Boss’ winner Munawar Faruqui among 14 detained after raid at hookah parlour in Mumbai
Cillian Murphy to star in mining drama ‘Blood Runs Coal’
MUST WATCH
Latest Additions
Bengaluru: Two arrested for illegally seizing auto over alleged loan default
To browbeat, bully others is vintage Congress culture: PM Modi on lawyers’ letter to CJI
Cong likely to hold meet on March 31 to finalise remaining LS poll candidates
ED questions AAP’s Goa unit chief, three others in money laundering case
K’taka govt writes to Union Health Minister urging urgent supply of anti-TB drugs to State